EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Retraction: The long non-coding RNA SNHG5 regulates gefitinib resistance in lung adenocarcinoma cells by targetting miR-377/CASP1 axis

ZheXing Wang, LiMing Pan, HaiXiang Yu, Yue Wang iD

Bioscience Reports · 19.08.2026 · 46 (8)

DOI: 10.1042/bsr20180400_ret ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience Reports, online erschienen am 30.07.2026. Verfasst von ZheXing Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin Province 130033, P.R. China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

SNHG5gefitinibhuman lung adenocarcinoma

Autor:innen und Institutionen

  • Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin Province 130033, P.R. China.
  • Department of Oncology, The First Hospital of Jilin University, Changchun, Jilin Province 130021, P.R. China.

ORCID-Profile: Yue Wang

Zitieren

APA

Wang, Z., Pan, L., Yu, H., & Wang, Y. (2026). Retraction: The long non-coding RNA SNHG5 regulates gefitinib resistance in lung adenocarcinoma cells by targetting miR-377/CASP1 axis. Bioscience Reports, 46(8). https://doi.org/10.1042/bsr20180400_ret

Vancouver

Wang Z, Pan L, Yu H, Wang Y. Retraction: The long non-coding RNA SNHG5 regulates gefitinib resistance in lung adenocarcinoma cells by targetting miR-377/CASP1 axis. Bioscience Reports. 2026;46(8). doi:10.1042/bsr20180400_ret

BibTeX
@article{Wang2026,
  author = {Wang, ZheXing and Pan, LiMing and Yu, HaiXiang and Wang, Yue},
  title = {Retraction: The long non-coding RNA SNHG5 regulates gefitinib resistance in lung adenocarcinoma cells by targetting miR-377/CASP1 axis},
  journal = {Bioscience Reports},
  year = {2026},
  volume = {46},
  number = {8},
  doi = {10.1042/bsr20180400_ret}
}
Kostenlos starten →